Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients

References

• McDonald LC, Killgore GE, Thompson A et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med.353(23), 2433–2441 (2005).
   PubMed Web of Science ®Google Scholar
• Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N. Engl. J. Med.298(10), 531–534 (1978).
   PubMed Web of Science ®Google Scholar
• McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003. Emerg. Infect. Dis.12(3), 409–415 (2006).
   PubMed Web of Science ®Google Scholar
• Blossom DB, McDonald LC. The challenges posed by reemerging Clostridium difficile infection. Clin. Infect. Dis.45(2), 222–227 (2007).
   PubMed Web of Science ®Google Scholar
• Owens RC. Clostridium difficile-associated disease: changing epidemiology and implications for management. Drugs67(4), 487–502 (2007).
   PubMedGoogle Scholar
• Kelly CP, LaMont JT. Clostridium difficile – more difficult than ever. N. Engl. J. Med.359(18), 1932–1940 (2008).
   PubMed Web of Science ®Google Scholar
• Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N. Engl. J. Med.346(5), 334–339 (2002).
   PubMed Web of Science ®Google Scholar
• Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N. Engl. J. Med.330(4), 257–262 (1994).
   PubMed Web of Science ®Google Scholar
• Chopra T, Chandrasekar PH, Salimnia H, Merline J, Alangaden GJ. Current epidemiology of Clostridium difficile associated disease (CDAD) in hematopoietic stem cell transplant recipients (HSCT). Presented at: 45th Annual Meeting Infectious Diseases Society of America (IDSA). San Diego, CA, USA, 4–7 October 2007.
   Google Scholar
• Bobak D, Arfons LM, Creger RJ, Lazarus HM. Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm? Bone Marrow Transplant.42(11), 705–713 (2008).
   PubMed Web of Science ®Google Scholar
• Bilgrami S, Feingold JM, Dorsky D et al. Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant.23(10), 1039–1042 (1999).
   PubMedGoogle Scholar
• Rampling A, Warren RE, Bevan PC et al.Clostridium difficile in haematological malignancy. J. Clin. Pathol.38(4), 445–451 (1985).
   PubMed Web of Science ®Google Scholar
• Heard SR, Wren B, Barnett MJ, Thomas JM, Tabaqchali S. Clostridium difficile infection in patients with haematological malignant disease. Risk factors, faecal toxins and pathogenic strains. Epidemiol. Infect.100(1), 63–72 (1988).
   PubMed Web of Science ®Google Scholar
• Raza S, Baig MA, Russell H, Gourdet Y, Berger BJ. Clostridium difficile infection following chemotherapy. Recent Pat. Antiinfect. Drug Discov.5(1), 1–9 (2010).
   PubMedGoogle Scholar
• Hornbuckle K, Chak A, Lazarus HM et al. Determination and validation of a predictive model for Clostridium difficile diarrhea in hospitalized oncology patients. Ann. Oncol.9(3), 307–311 (1998).
   PubMed Web of Science ®Google Scholar
• Dubberke ER, Reske KA, Srivastava A et al.Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes. Clin. Transplant.24(2), 192–198 (2009).
   PubMedGoogle Scholar
• Dubberke ER, Riddle DJ. Clostridium difficile in solid organ transplant recipients. Am. J. Transplant.9(Suppl. 4), S35–S40 (2009).
   PubMedGoogle Scholar
• Anand A, Glatt AE. Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin. Infect. Dis.17(1), 109–113 (1993).
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP, Lewis RE, Marr K. The burden of bacterial and viral infections in hematopoietic stem cell transplant. Biol. Blood Marrow Transplant.15(1 Suppl.), 128–133 (2009).
   PubMed Web of Science ®Google Scholar
• Husain A, Aptaker L, Spriggs DR, Barakat RR. Gastrointestinal toxicity and Clostridium difficile diarrhea in patients treated with paclitaxel-containing chemotherapy regimens. Gynecol. Oncol.71(1), 104–107 (1998).
   PubMed Web of Science ®Google Scholar
• Emoto M, Kawarabayashi T, Hachisuga MD, Eguchi F, Shirakawa K. Clostridium difficile colitis associated with cisplatin-based chemotherapy in ovarian cancer patients. Gynecol. Oncol.61(3), 369–372 (1996).
   PubMed Web of Science ®Google Scholar
• Gorschluter M, Glasmacher A, Hahn C et al.Clostridium difficile infection in patients with neutropenia. Clin. Infect. Dis.33(6), 786–791 (2001).
   PubMed Web of Science ®Google Scholar
• Fainstein V, Bodey GP, Fekety R. Relapsing pseudomembranous colitis associated with cancer chemotherapy. J. Infect. Dis.143(6), 865 (1981).
   PubMed Web of Science ®Google Scholar
• Silva J, Fekety R, Werk C et al. Inciting and etiologic agents of colitis. Rev. Infect. Dis.6(Suppl. 1), S214–S221 (1984).
   PubMedGoogle Scholar
• Yamazawa K, Kanno H, Seki K et al. Life-threatening Clostridium difficile-associated diarrhea induced by paclitaxel-carboplatin combination chemotherapy. Acta Obstet. Gynecol. Scand.80(8), 768–769 (2001).
   PubMed Web of Science ®Google Scholar
• Ansari J, Choo B, Fernando I. Fatal Clostridium difficile infection associated with vinorelbine chemotherapy: case report and literature review. J. Infect. Chemother.16(3), 210–212 (2010).
   PubMedGoogle Scholar
• Maeda Y, Yamazaki K, Kikuchi E et al. [A case of Clostridium difficile colitis associated with paclitaxel and carboplatin chemotherapy for lung cancer]. Nihon Kokyuki Gakkai Zasshi43(11), 668–672 (2005).
   PubMedGoogle Scholar
• Taylor SG, Hass GM, Crumrine JL, Slaughter DP. Toxic reactions of 4-amino-pteroylglutamic acid (aminopterin) in patients with far-advanced neoplastic disease. Cancer3(3), 493–503 (1950).
   PubMed Web of Science ®Google Scholar
• Boukhettala N, Leblond J, Claeyssens S et al. Methotrexate induces intestinal mucositis and alters gut protein metabolism independently of reduced food intake. Am. J. Physiol. Endocrinol. Metab.296(1), E182–E190 (2009).
   Google Scholar
• Stringer AM, Gibson RJ, Logan RM et al. Faecal microflora and β-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats. Cancer Biol. Ther.7(12), 1919–1925 (2008).
   PubMed Web of Science ®Google Scholar
• Larson HE, Price AB, Borriello SP. Epidemiology of experimental enterocecitis due to Clostridium difficile. J. Infect. Dis.142(3), 408–413 (1980).
   PubMed Web of Science ®Google Scholar
• Toshniwal R, Silva J Jr, Fekety R, Kim KH. Studies on the epidemiology of colitis due to Clostridium difficile in hamsters. J. Infect. Dis.143(1), 51–54 (1981).
   PubMed Web of Science ®Google Scholar
• Johnson S, Clabots CR, Linn FV et al. Nosocomial Clostridium difficile colonisation and disease. Lancet336(8707), 97–100 (1990).
   PubMed Web of Science ®Google Scholar
• Loo VG, Poirier L, Miller MA et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med.353(23), 2442–2449 (2005).
   PubMed Web of Science ®Google Scholar
• Rojas S, Cohen SH, Tang YJ et al. Differing epidemiology of Clostridium difficile-associated diarrhea between an oncology ward and a general medicine ward. Infect. Control Hosp. Epidemiol.20(1), 14–15 (1999).
   PubMedGoogle Scholar
• Cohen SH, Tang YJ, Muenzer J, Gumerlock PH, Silva J Jr. Isolation of various genotypes of Clostridium difficile from patients and the environment in an oncology ward. Clin. Infect. Dis.24(5), 889–893 (1997).
   PubMedGoogle Scholar
• Chopra T, Bernabela L, MacNamara S et al. Molecular and epidemiological characterization of Clostridium difficile strains in a tertiary care hospital. Presented at: 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Fransisco, CA, USA, 12–15 September 2009 (Abstract K 2080).
   Google Scholar
• Cohen SH, Gerding DN, Johnson S et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect. Control Hosp. Epidemiol.31(5), 431–455 (2010).
   PubMed Web of Science ®Google Scholar
• Mossad SB, Longworth DL, Goormastic M et al. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients. Bone Marrow Transplant.18(2), 265–271 (1996).
   PubMed Web of Science ®Google Scholar
• Avery R, Pohlman B, Adal K et al. High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients. Bone Marrow Transplant.25(1), 67–69 (2000).
   PubMedGoogle Scholar
• van Kraaij MG, Dekker AW, Verdonck LF et al. Infectious gastro-enteritis: an uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients. Bone Marrow Transplant.26(3), 299–303 (2000).
   PubMed Web of Science ®Google Scholar
• Barton T, Collis T, Stadtmauer E, Schuster M. Infectious complications the year after autologous bone marrow transplantation or peripheral stem cell transplantation for treatment of breast cancer. Clin. Infect. Dis.32(3), 391–395 (2001).
   PubMed Web of Science ®Google Scholar
• Yuen KY, Woo PC, Liang RH et al. Clinical significance of alimentary tract microbes in bone marrow transplant recipients. Diagn. Microbiol. Infect. Dis.30(2), 75–81 (1998).
   PubMedGoogle Scholar
• Arango JI, Restrepo A, Schneider DL et al. Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant.37(5), 517–521 (2006).
   PubMed Web of Science ®Google Scholar
• Dettenkofer M, Ebner W, Bertz H et al. Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation. Bone Marrow Transplant.31(9), 795–801 (2003).
   PubMed Web of Science ®Google Scholar
• Jank T, Giesemann T, Aktories K. Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function. Glycobiology17(4), R15–R22 (2007).
   PubMed Web of Science ®Google Scholar
• Bobak DA. The molecular pathogenesis of Clostridium difficile-associated disease. Curr. Infect. Dis. Rep.10(2), 111–115 (2008).
   PubMedGoogle Scholar
• Kyne L, Farrell RJ, Kelly CP. Clostridium difficile. Gastroenterol. Clin. North Am.30(3), 753–777; IX–X (2001).
   PubMed Web of Science ®Google Scholar
• Chakrabarti S, Lees A, Jones SG, Milligan DW. Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality. Bone Marrow Transplant.26(8), 871–876 (2000).
   PubMed Web of Science ®Google Scholar
• Peterson LR, Robicsek A. Does my patient have Clostridium difficile infection? Ann. Intern. Med.151(3), 176–179 (2009).
   PubMed Web of Science ®Google Scholar
• Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin. Microbiol. Infect.15(12), 1053–1066 (2009).
   PubMed Web of Science ®Google Scholar
• Peterson LR, Manson RU, Paule SM et al. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin. Infect. Dis.45(9), 1152–1160 (2007).
   PubMed Web of Science ®Google Scholar
• Eastwood K, Else P, Charlett A, Wilcox M. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J. Clin. Microbiol.47(10), 3211–3217 (2009).
   PubMed Web of Science ®Google Scholar
• Bauer MP, Kuijper EJ, van Dissel JT. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin. Microbiol. Infect.15(12), 1067–1079 (2009).
   PubMed Web of Science ®Google Scholar
• Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin. Infect. Dis.45(3), 302–307 (2007).
   PubMed Web of Science ®Google Scholar
• Nielsen H, Daugaard G, Tvede M, Bruun B. High prevalence of Clostridium difficile diarrhoea during intensive chemotherapy for disseminated germ cell cancer. Br. J. Cancer66(4), 666–667 (1992).
   PubMed Web of Science ®Google Scholar
• Paterson DL. Clostridium difficile diarrhoea associated with chemotherapy for ovarian cancer. Aust. NZJ Obstet. Gynaecol.37(3), 348–349 (1997).
   PubMedGoogle Scholar
• Wong AS, Lam CS, Tambyah PA. Fatal chemotherapy associated Clostridium difficile infection – a case report. Singapore Med. J.42(5), 214–216 (2001).
   PubMedGoogle Scholar
• Morales Chamorro R, Serrano Blanch R, Mendez Vidal MJ et al. Pseudomembranous colitis associated with chemotherapy with 5-fluorouracil. Clin. Transl. Oncol.7(6), 258–261 (2005).
   PubMedGoogle Scholar
• Yang SW, Moon W. [A case of pseudomenbranous colitis after paclitaxel and carboplatin chemotherapy]. Korean J. Gastroenterol.54(5), 328–332 (2009).
   PubMedGoogle Scholar
• Cox GJ, Matsui SM, Lo RS et al. Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology107(5), 1398–1407 (1994).
   PubMed Web of Science ®Google Scholar
• Tomblyn M, Gordon L, Singhal S et al. Rarity of toxigenic Clostridium difficile infections after hematopoietic stem cell transplantation: implications for symptomatic management of diarrhea. Bone Marrow Transplant.30(8), 517–519 (2002).
   PubMed Web of Science ®Google Scholar
• Jillella AP, Ustun C, Robach E et al. Infectious complications in patients receiving mobilization chemotherapy for autologous peripheral blood stem cell collection. J. Hematother. Stem Cell Res.12(2), 155–160 (2003).
   PubMedGoogle Scholar